The RELENZA brand, founded in 2006 (United Kingdom), from 1722 sister brands and 17478 competing brands. The RELENZA brand is owned by GSK PLC, a company listed in London. The International Securities Identification Number (ISIN) of GSK PLC is GB00BN7SWP63. The sector of RELENZA is Drug Manufacturers.

RELENZA is a brand of GSK PLC (GSK/L) Share price

International deposit : 2006 Business sector Drug Manufacturers

Share price and profitability of the share GSK PLC (RELENZA)

Buy GSK PLC share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested GBX 1,745.00

Portfolio valuation
GSK PLC (RELENZA) over 5 years* GBX 1,583.48

Stock market history GSK PLC (RELENZA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
GSK PLC

Twinrix
Twinrix
Trizivir
Trizivir
Triumeq
Triumeq
Retrovir
Retrovir
Pediarix
Pediarix
Mepron
Mepron
See more brands of GSK PLC

Rival brands
RELENZA

Fusion Pharmaceuticals
Fusion Pharmaceuticals
POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS